Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -155,676 | -86,432 | -248,497 | -181,599 | -117,144 |
| Depreciation Amortization | 2,739 | 1,292 | 2,455 | 1,409 | 657 |
| Accounts receivable | -25 | -772 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,359 | 191 | 6,200 | 4,321 | 5,466 |
| Other Working Capital | -9,992 | -4,198 | 13,079 | 9,310 | 5,728 |
| Other Operating Activity | 34,675 | 18,107 | 31,355 | 23,714 | 13,298 |
| Operating Cash Flow | $-126,920 | $-71,812 | $-195,408 | $-142,845 | $-91,995 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -807 | -319 | -8,047 | -7,094 | -4,860 |
| Purchase Of Investment | -32,457 | -32,457 | -166,321 | -139,398 | -106,980 |
| Sale Of Investment | 59,369 | 37,640 | 286,267 | 213,900 | 127,146 |
| Investing Cash Flow | $26,105 | $4,864 | $111,899 | $67,408 | $15,306 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 85,000 | 85,000 | 40,000 | 40,000 | 40,000 |
| Debt Repayment | N/A | N/A | -3,856 | -3,856 | -3,856 |
| Other Financing Activity | 202,476 | 200,476 | 19,734 | 8,626 | 5,598 |
| Financing Cash Flow | $287,476 | $285,476 | $55,878 | $44,770 | $41,742 |
| Exchange Rate Effect | 18 | 10 | N/A | N/A | N/A |
| Beginning Cash Position | 79,880 | 79,880 | 107,511 | 107,511 | 107,511 |
| End Cash Position | 266,559 | 298,418 | 79,880 | 76,844 | 72,564 |
| Net Cash Flow | $186,679 | $218,538 | $-27,631 | $-30,667 | $-34,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -126,920 | -71,812 | -195,408 | -142,845 | -91,995 |
| Capital Expenditure | -807 | -319 | -8,047 | -7,094 | -4,860 |
| Free Cash Flow | -127,727 | -72,131 | -203,455 | -149,939 | -96,855 |